Mark Alan Goldberg Insider Trading $IDRA IDERA PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark Alan Goldberg.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark Alan Goldberg. Mark Alan Goldberg is Director in IMMUNOGEN INC ($IMGN) and Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and Director in GLYCOMIMETICS INC ($GLYC) and Director in aTYR PHARMA INC ($LIFE) and Director in Blueprint Medicines Corp ($BPMC) and Director in Audentes Therapeutics, Inc. ($BOLD).
Mark Alan Goldberg in IDERA PHARMACEUTICALS, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Mark Alan Goldberg: Director
Holdings: 38,099 shares
Current Value: $59,434
Latest Transaction: Jan 06 2021
$IDRA Market Capitalization: $230.34M
$IDRA Previous Close: $1.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Mark Alan Goldberg in IDERA PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, LIFE, BOLD, BPMC, GLYC, IDRA, IMGN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 06 2021 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Grant | A | 4.02 | 3,452 | 13,877 | 38,099 | 34.6 K to 38.1 K (+9.96 %) |
| Oct 05 2020 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Grant | A | 2.25 | 6,166 | 13,874 | 34,647 | 28.5 K to 34.6 K (+21.65 %) |
| Jul 02 2020 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Grant | A | 1.79 | 7,751 | 13,874 | 28,481 | 20.7 K to 28.5 K (+37.39 %) |
| May 19 2020 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Option Exercise | A | 1.97 | 11,500 | 22,655 | 11,500 | |
| Apr 03 2020 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Grant | A | 1.28 | 10,730 | 13,734 | 20,730 | 10 K to 20.7 K (+107.30 %) |
| Jun 06 2019 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Option Exercise | A | 2.57 | 11,500 | 29,555 | 11,500 | |
| Dec 20 2018 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Buy | P | 3.19 | 10,000 | 31,897 | 10,000 | 0 to 10 K |
| Jun 22 2018 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Option Exercise | A | 1.53 | 50,000 | 76,500 | 50,000 | |
| Jun 09 2017 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Option Exercise | A | 1.63 | 50,000 | 81,500 | 50,000 | |
| Jun 15 2016 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Option Exercise | A | 1.44 | 35,000 | 50,400 | 35,000 | |
| Jun 10 2015 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Option Exercise | A | 3.59 | 35,000 | 125,650 | 35,000 |
Page: 1